Next Progeny Pty., Ltd.
USPTO PatentsView assignee record - 20 granted patents across 0 technology areas, recorded in grant years 2019–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength.
The verdict
According to USPTO PatentsView, Next ranks #14,813 of 49,997 tracked US assignees by granted-patent volume, with 20 patents across 0 technology areas.
- #14,813
- of 49,997 US assignees by volume
- 2nd percentile
- by Innovation Score (12.3/100)
- 1.0
- avg claims per patent
- +200%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R14813 · Foreign Corporation #14,813 · 20 grants
GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-UNK · INNOV-LOW · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-SURGE · BOOK-RICH
- GRANTS-SMALL 20 grants
- MID-PACK #14,813/49,997
- PHOTO-FINISH Network Performance…
- CPC-UNK CPC blank
- INNOV-LOW 12.3/100
- CLAIMS-SPARSE 1.0 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-SURGE +200% vel
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: Network Performance Research Group LLC (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Next’s 12.3 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Next
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Next Progeny Pty · this assignee 12
Next Progeny Pty · this assignee
12 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Next's Innovation Score is 12.3/100 (2nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Next?
Each dot is one of Next’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Next’s own 1.0 claims/patent is at or below the 18.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Next's grants concentrate
Next Progeny Pty., Ltd. is a focused PatentsView assignee: 0 CPC subclasses . Peak complete grant year is 2021 (12 grants) versus a trough of 1 in 2023. By volume, Next sits between Network Performance Research Group LLC and Nocion Therapeutics, Inc..
Next's three-year grant acceleration
Next Progeny Pty., Ltd. shows 3 grants in 2022–2024 against only 17 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Next's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Network Performan…
Network Performance Research Group LLC
20 patents
- Neurent Medical
Neurent Medical Limited
20 patents
- Nexplanar
NexPlanar Corporation
20 patents
- Nexgen Power Syst…
Nexgen Power Systems, Inc.
20 patents
- Nichicon
Nichicon Corporation
20 patents
- Ningbo Gemay Indu…
Ningbo Gemay Industry Company Limited
20 patents
- Nistica
Nistica, Inc.
20 patents
- Nocion Therapeuti…
Nocion Therapeutics, Inc.
20 patents
- Next Progeny Pty ◀
Next Progeny Pty., Ltd.
20 patents
What this shows Next holds 20 patents at rank #14,811, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Next
By rank, the assignees closest to #14,811 in granted patent volume.
- Network Performance Research Group LLC #14,807 · 20 patents
- Neurent Medical Limited #14,808 · 20 patents
- NexPlanar Corporation #14,809 · 20 patents
- Nexgen Power Systems, Inc. #14,810 · 20 patents
- Nichicon Corporation #14,812 · 20 patents
- Ningbo Gemay Industry Company Limited #14,813 · 20 patents
- Nistica, Inc. #14,814 · 20 patents
- Nocion Therapeutics, Inc. #14,815 · 20 patents
Next's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
12 2nd percentile higher than 2% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2019 | 5 | 25.0% |
| 2021 | 12 | 60.0% |
| 2022 | 2 | 10.0% |
| 2023 | 1 | 5.0% |
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Next Progeny Pty., Ltd.'s patent record in context - here's where to go next.
- Ranked #14,813 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Next Progeny Pty., Ltd. against Network Performance Research Group LLC, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 12.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.